LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that six posters on its iCALM™ and iSPERSE™ inhaled drug platforms have been selected for presentation at the American Thoracic Society (ATS) 2012 International Conference taking place May 18-23, 2012, in San Francisco, CA.